Suboptimal cardiovascular ultrasound imaging can produce transthoracic echocardiograms (TTEs) that are inconclusive, resulting in negative patient outcomes and financial implications such as added costs for more testing. See why cSound software-beamforming technology from GE Healthcare addresses these challenges to potentially lessen patient burden, lower costs and improve patient care.
If you enjoy this content, please share it with a colleague
GE cSound May Help Reduce the Burden of Inconclusive TTEs
Related Content
May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the ...
April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...
August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...
July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...
February 10, 2023 — GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement ...
Sudden cardiac arrest is a complex and challenging medical emergency because it can occur anywhere at any time and is ...
August 9, 2022 — Butterfly Medical, an Israeli medical device company developing a novel minimally invasive solution to ...
July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first patient ...
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it ...
Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to ...